Report
Nikolaas Faes

AURORA CANNABIS: Still the stock to avoid | SELL vs. NEUTRAL | CAD1.1 vs. CAD7 (-45%)

AURORA CANNABIS - SELL vs. NEUTRAL | CAD1.1 vs. CAD7 (-45%)
Still the stock to avoid

Downgrading to Sell
Another flat quarter to come
Competitive cost to grow
Underlying
Aurora Cannabis Inc.

Aurora Cannabis is engaged in the acquisition, exploration and development of resource properties, primarily in Canada.

Provider
Bryan Garnier
Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

Analysts
Nikolaas Faes

Other Reports on these Companies
Other Reports from Bryan Garnier

ResearchPool Subscriptions

Get the most out of your insights

Get in touch